SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-22-026239
Filing Date
2022-12-08
Accepted
2022-12-08 16:18:43
Documents
13
Period of Report
2022-12-07
Items
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rkda-20221207.htm   iXBRL 8-K 86937
2 EX-3.2 rkda-ex3_2.htm EX-3.2 8636
  Complete submission text file 0000950170-22-026239.txt   221334

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rkda-20221207_lab.xml EX-101.LAB 13905
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rkda-20221207.xsd EX-101.SCH 2463
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rkda-20221207_pre.xml EX-101.PRE 10226
7 EXTRACTED XBRL INSTANCE DOCUMENT rkda-20221207_htm.xml XML 4853
Mailing Address 202 COUSTEAU PLACE SUITE 105 DAVIS CA 95618
Business Address 202 COUSTEAU PLACE SUITE 105 DAVIS X1 95618 530-756-7077
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

IRS No.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37383 | Film No.: 221452785
SIC: 0100 Agricultural Production-Crops